Allergan Receives Written Response from FDA on Oral Tazarotene for Psoriasis

Wed, 01 Jun 2005 04:00 PM EST

... Allergan, Inc has received a written response from the US Food and Drug Administration (FDA) regarding Allergan''s request for formal dispute resolution on its oral tazarotene capsule New Drug Application (NDA)... click link for more info. ...